German Pharmacists Warn Against Online Cannabis Prescriptions
The German Pharmacists' Association (BAK) has issued a warning against obtaining prescription drugs, particularly medical cannabis, through online platforms. They cite concerns over a lack of direct doctor-patient contact and adequate medical assessment.
The German Pharmacists' Association (Bundesapothekerkammer, BAK) has issued a resolution cautioning against the procurement of prescription medications via online platforms. The organization highlights concerns that these platforms often issue prescriptions for medical cannabis and other sensitive drugs based on standardized questionnaires, bypassing necessary doctor-patient consultations and potentially compromising patient safety.
According to the BAK, it is increasingly problematic that these online services are not merely facilitating orders but actively involved in "obtaining" prescriptions. The association states that prescriptions are frequently issued without a personal physician-patient interaction, relying on minimal diagnostic depth through online forms. This process, the BAK argues, reduces the act of medical prescription to a mere ordering procedure, undermining the purpose of prescription requirements and the necessity of medical indication.
The BAK is calling on policymakers and regulatory authorities to bolster patient-oriented healthcare structures to safeguard public health. President Dr. Armin Hoffmann emphasized that access to prescription drugs like medical cannabis should not be subjected to the commercial interests of digital trading platforms. He expressed support for discussions on this issue at the upcoming federal states' health ministers' conference.
The resolution was unanimously adopted by the presidents of the 17 regional pharmacists' chambers in Germany. They advocate for strengthening professional healthcare structures to ensure that prescription medications are dispensed responsibly and with appropriate medical oversight.